You are here

Pharma CEOs

Struggling Insys swaps CEOs as Subsys marketing crackdown continues

Struggling Insys swaps CEOs as Subsys marketing crackdown continues

Fierce Pharma

INSYS Therapeutics

Flag link:

Revenue plunges, stock takes a drubbing, but Teva CEO Kåre Schultz still grabs $32.5M in chart-topping compensation

Revenue plunges, stock takes a drubbing, but Teva CEO Kåre Schultz still grabs $32.5M in chart-topping compensation

Endpoints

Teva Pharmaceutical

Flag link:

Biopharma CEOs Explain Problems With Biosimilars to Congress

Biopharma CEOs Explain Problems With Biosimilars to Congress

RAPS.org

Flag link:

Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene

Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene

CNBC

Bristol-Myers Squibb

Giovanni Caforio

Flag link:

It’s a seller’s world in biotech M&A, and Novartis CEO Vas Narasimhan has his check book out and pen ready

It’s a seller’s world in biotech M&A, and Novartis CEO Vas Narasimhan has his check book out and pen ready

Endpoints

Flag link:

Novartis CEO's $50 Billion of Deals Was Just the First Act

Novartis CEO's $50 Billion of Deals Was Just the First Act

Yahoo/Bloomberg

Flag link:

AbbVie shareholder joins the growing ranks of critics, calling for an independent chairman

AbbVie shareholder joins the growing ranks of critics, calling for an independent chairman

Endpoints

Richard Gonzalez

Flag link:

Alexion chief registers $16.5M in pay after a solid year, with a relatively low 74-to-1 ratio compared to a well paid staff

Alexion chief registers $16.5M in pay after a solid year, with a relatively low 74-to-1 ratio compared to a well paid staff

Endpoints

Flag link:

After landing a historic FDA OK, Alnylam chief John Maraganore scores a big raise

After landing a historic FDA OK, Alnylam chief John Maraganore scores a big raise

Endpoints

John Maraganore

Flag link:

Exclusive: Sanofi says working on CEO succession plan

Exclusive: Sanofi says working on CEO succession plan

Yahoo/Reuters

Olivier Brandicourt

Flag link:

J&J chief Alex Gorsky suffers a big drop in compensation, but still comes out way ahead of most major league CEOs

J&J chief Alex Gorsky suffers a big drop in compensation, but still comes out way ahead of most major league CEOs

Endpoints

Flag link:

Ian Read bags $19.5 million, taking a big pay cut for his swan song as Pfizer CEO and leaving the pharma giant at a crossroads

Ian Read bags $19.5 million, taking a big pay cut for his swan song as Pfizer CEO and leaving the pharma giant at a crossroads

Endpoints

Flag link:

Lilly CEO David Ricks snags $17.2M pay package for 2018, a 9% hike

Lilly CEO David Ricks snags $17.2M pay package for 2018, a 9% hike

Fierce Pharma

Flag link:

Emma Walmsley earns £1M pay rise in her first full year at GSK's helm — but £5.9M package still trails other Big Pharma CEOs

Emma Walmsley earns £1M pay rise in her first full year at GSK's helm — but £5.9M package still trails other Big Pharma CEOs

Endpoints

Flag link:

Two big pharma execs share the same challenges, but compensation? They’re not even close

Two big pharma execs share the same challenges, but compensation? They’re not even close

Endpoints

Richard Gonzalez

Olivier Brandicourt

Flag link:

What do Allergan activists really want? A new CEO to replace Saunders, analyst says

What do Allergan activists really want? A new CEO to replace Saunders, analyst says

Fierce Pharma

Flag link:

Bad year at Celgene? Forget about it. CEO Mark Alles nabbed a big raise as compensation gyrated to $16.2M

Bad year at Celgene? Forget about it. CEO Mark Alles nabbed a big raise as compensation gyrated to $16.2M

Endpoints

Flag link:

Was AstraZeneca CEO Pascal Soriot happy with his $14.8M in '18 compensation? Probably not so much

Was AstraZeneca CEO Pascal Soriot happy with his $14.8M in '18 compensation? Probably not so much

Endpoints

Flag link:

Sorry, Allergan. Another activist backs an immediate split to CEO, chairman jobs

Sorry, Allergan. Another activist backs an immediate split to CEO, chairman jobs

Fierce Pharma

Flag link:

Under-pressure Allergan backs a CEO-chairman job split—just not right now

Under-pressure Allergan backs a CEO-chairman job split—just not right now

Fierce Pharma

Flag link:

Pages